Insulin's role in non-diabetic heart attack patients
Part of Hormones & metabolism clinical trials.
This study looks at how insulin resistance affects recovery after a heart attack or unstable angina in people without diabetes. It may help understand why some patients have worse outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with acute coronary syndrome (heart attack or unstable angina).
- You do not have diabetes or any history of diabetes.
- You are willing and able to attend follow-up appointments.
- You do not have severe medical conditions like cirrhosis, cancer, severe lung disease, heart failure, or kidney failure.
- You must have survived until reaching the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how your body handles sugar and related hormones in people after a new STEMI heart attack, and compares them with people who do not have diabetes or have prediabetes. The goal is to better understand metabolic changes after the event, which could help future care.
This study looks at how insulin resistance affects tiny heart arteries in people who have chest pain and signs of heart stress on tests, but do not have major blockages in their heart arteries. It aims to understand why some people have heart symptoms even when their main arteries appear clear.
This study looks at how insulin affects blood vessels and the brain in people with obesity and insulin resistance, compared to healthy-weight individuals. It may help explain why obesity raises heart and blood vessel risks.
This study looks at how the heart uses energy fuel in people with heart failure, including those with type 2 diabetes. It may help researchers understand what’s going on inside the heart and how it could be treated in the future.
This study looks at how insulin resistance affects blood flow after a common heart attack procedure (stenting) in people with type 2 diabetes. It may help doctors understand why some patients have poor blood flow after treatment.
This study compares short-term outcomes in people with type 2 diabetes who have a heart attack and receive a stent, depending on whether they were taking insulin or oral diabetes medications before the event. It aims to see if one treatment leads to better recovery.
Hear when a new Insulin Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.